From: Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data
Triptan users without overuse n = 31,092 | Triptan overusers n = 1970 | Statistics p-value | |||
---|---|---|---|---|---|
Triptans DDD/year | |||||
Median | 12 | 102 | < 0.001# | ||
Lower quartile | 6 | 84 | |||
Upper quartile | 32 | 132 | |||
Range | 1–106 | 30–762 | |||
Age (years) | |||||
Median | 44 | 47 | < 0.001# | ||
Lower quartile | 35 | 40 | |||
Upper quartile | 52 | 55 | |||
Age group (years) | n | % | n | % | |
18–35 | 8051 | 25.9 | 292 | 14.8 | < 0.001§ |
36–50 | 14,216 | 45.7 | 918 | 46.6 | |
51–65 | 7210 | 23.2 | 396 | 30.3 | |
66–99 | 1615 | 5.2 | 164 | 8.3 | |
Sex | |||||
Female | 25,623 | 82.4 | 1631 | 82.8 | 0.666 |
Male | 5469 | 17.6 | 339 | 17.2 |